Large-scale iPSC production system aimed at clinical therapy funded by NIH
Allele Biotechnology and Pharmaceuticals (San Diego, CA, USA) has been awarded a Phase I SBIR grant by the NIH’s NHLBI to support the development of a large-scale, clinical-grade induced pluripotent stem cell manufacturing system aimed at producing stem cell-derived cells and tissues for clinical application.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.